NYSCF Press Releases
The National Stem Cell Foundation (NSCF) and the NYSCF Research Institute announced that a grant from NSCF will be used to fund NYSCF research on cell to cell crosstalk in neurodegeneration being conducted by Dr. Valentina Fossati, a NYSCF Senior Investigator, and her team.   The researchers are studying how…
The NYSCF Research Institute announced a new collaboration with Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfiling, to generate induced pluripotent stem cell (iPSC) lines for use in discovery efforts focused on new medicines for neurodegenerative diseases like ALS, Alzheimer's Disease, Parkinson's Disease,…
Stem cell lines resulting from a pathbreaking collaboration beginning in 2014 between The NYSCF Research Institute and the Charcot-Marie-Tooth Association (CMTA) are now available for use by other researchers in the largest and first ever initiative of its kind.   The CMTA provided and coordinated nineteen patients with a number…
NYSCF has been at the forefront of bringing mitochondrial replacement therapy to the clinic and in 2011, published a seminal paper in Nature that showed mitochondrial replacement could be done successfully with human oocytes. Our scientists have been working since then to ensure this procedure would be safe and efficacious when brought…
After marking it's 10th Anniversary, NYSCF is excited to announce a 2016 move to the far west side after signing a multi-year lease for 42,000 square-feet at Taconic Partners LLC 619 West 54th Street. The 10-story, 333,000-square-foot Art Deco building will be the new home of the NYSCF offices and…
At The 2015 NYSCF Conference: Tenth Annual Translational Stem Cell Research Conference, NYSCF announced Franziska Michor. PhD, as the 2015 recipient of the Robertson Stem Cell Prize. Dr. Michor fuses her passions in mathematics, molecular biology and patient care to investigate how cancers form and progress. As a Professor of…
Five new NYSCF – Robertson Investigators join the prestigious community of early career scientists making the transition from post-doctoral research to their own labs. The three new 2015 NYSCF – Robertson Stem Cell Investigators, Mitchell Guttman, PhD, Justin Ichida, PhD, and Kristy Red-Horse, PhD, each receive funds to disbursed over…
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to address moving cures from research results to patients’ hands. This year, two nobel laureates will chair panels and participate in discussions on “Transformative Technologies”…
NYSCF and CBR Systems, Inc. DBA Cord Blood Registry (CBR) are collaborating to customize the creation of high-quality stem cell lines from umbilical cord blood tissue. NYSCF will create induced pluripotent stem (iPS) cell lines from umbilical cord tissue collected after birth from healthy newborns provided by CBR. The partnership…
NYSCF announces a new partnership with Q-State Biosciences (Q-State) to generate high quality stem cells from patient blood cells. The collaboration will mark the first time the generation of induced pluripotent stem (iPS) cells from blood cells will be automated with high-throughput massively parallel technology. The NYSCF Global Stem Cell…
Page 1 of 10
You are here: News Press Releases